Mesotherapy for hair loss

Key takeaways

• Mesotherapy is a delivery method, not a drug; what matters is what is in the syringe. Reviews list six groups of agents studied: dutasteride, minoxidil, growth factors, botulinum toxin, stem cell products, and vitamin or peptide mixes (Gupta 2023). A 2026 review of 30 studies found multivitamin and peptide mixes most often studied, then dutasteride and minoxidil (Beer 2026).
• Reviews are cautious. The 2026 review concluded injectable therapy may give cosmetic benefit, particularly with dutasteride, but evidence is limited by small samples, variable protocols and short follow-up (Beer 2026). A 2023 review of 27 articles found no standardized regimens (Gupta 2023).
• Dutasteride mesotherapy is unapproved and mostly observational. In a multicentre retrospective study of 541 patients, improvement was seen in most of the 86 assessable at one year (marked in 38.4%). Pain was the commonest effect (45.5%) with no serious or sexual events, but only about 16% of the cohort could be assessed, so the result is heavily filtered (Saceda-Corralo 2022).
• A cleaner look found no benefit. In 10 patients given 0.1% dutasteride (1.25 mL per round, roughly every 3 months), density improved in 2, did not change in 4 and varied by site in 4, with no significant change (Nohria 2024).
• The injections can cause new bald patches. Case series describe persistent patches after dutasteride mesotherapy in women, after as little as one session (Nogueira 2026), and patchy non-scarring alopecia at injection sites in 4 of 15 patients after one session of a 0.01% preparation (Chandrashekhar 2025). How often this happens is unknown.
• Natural cocktails have almost no controlled evidence. In 30 women over 12 weeks, nutritional mesotherapy did not differ from 5% minoxidil lotion in density, though patients were more satisfied with injections (Hunter 2019). Satisfaction is not growth.
• Intradermal minoxidil has placebo-controlled support with small numbers. In 54 women, 0.5% minoxidil injected intradermally beat saline on terminal-to-vellus hair ratio and share of growing hairs (Uzel 2021).
• A 2026 pilot of 40 adults found 10% glucose plus hyaluronic acid beat hyaluronic acid alone on density at week 18 (+19.3 vs +6.2 hairs per cm2), in an unregistered single-centre study (Yi 2026).

What it is

Low doses are delivered into the skin of the scalp by hand syringe, a multi-needle gun or a microneedle device. The theory is that a skin depot gives the follicle longer contact and allows smaller total doses, possibly lowering whole-body exposure compared with oral drugs. That idea is largely untested: blood pressure falls after scalp microinfusion of minoxidil show the drug can still reach the bloodstream (see microneedling). Many commercial cocktails contain growth factors, conditioned media or exosomes (see stem cell and growth factor treatments and exosomes).

What the studies show

See the key takeaways above. Overall the positive series mostly lack controls, and the only randomized comparisons involve minoxidil or non-drug agents rather than dutasteride. Most trials are tiny and short (6 to 24 weeks) and come from single clinics.

How it's used in studies

Studies used dutasteride 0.01 to 0.1% in about 1.25 to 2 mL per session, monthly to every 3 months, and minoxidil 0.5% injected intradermally. There is no approved injectable dutasteride or finasteride for hair, so preparations are compounded and concentration, sterility and additives vary. Oral dutasteride and finasteride carry pregnancy warnings, and the injected route does not remove that concern for people who could become pregnant; absorption from scalp injection is not well studied (see dutasteride and finasteride).

Side effects and safety

• Pain is the commonest effect.
• New bald patches, possibly scarring, have been reported after dutasteride mesotherapy, and preservatives or other components may be to blame (Chandrashekhar 2025).
• A new patch, tenderness, swelling or pus within weeks of a session needs a dermatologist's review, because scarring changes are hard to reverse.
• Avoid injections into an infected or inflamed scalp.

Bottom line

Mesotherapy is a niche option for people who cannot or will not take oral drugs, and it should follow approved treatments (see the treatment ladder). Ask exactly what is in the syringe, who compounded it, and what happens if a bald patch appears. Discuss with a doctor.